HopeStage
Back to all studies
WithdrawnNCT05173116

Evaluation of the API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism

Observational studyAges 18+FranceAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: February 2022
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Centre Hospitalier Arras
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
OTHER
Study phase
Not clearly listed
Locations
France
Age range
Over 18 Years
Official registry ID
NCT05173116
Official title
Show the full official title

Evaluation of API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism

Recruitment & locations

Withdrawn

Arras

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre Hospitalier Arras.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies